跳至主要内容
临床试验/NCT04465929
NCT04465929No Longer Available不适用

Expanded Access - The Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury (PNI)

W. Dalton Dietrich1 个研究点 分布在 1 个国家开始时间: 2020年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
No Longer Available
发起方
试验地点
1

研究概览

简要总结

Emergency expanded access for a single patient was granted to receive autologous human Schwann cell (ahSC) augmentation of nerve autograft repair after severe peripheral nerve injury (PNI).

研究设计

研究类型
Expanded Access

入排标准

年龄范围
16 Years 至 16 Years(Child)
性别
Female
接受健康志愿者

入选标准

  • Persons with severe sciatic nerve injury, brachial plexus injury, and/or major injury at the upper or lower extremity with nerve loss within previous year;
  • Peripheral nerve injury with large gap (5 - 10 cm) between healthy nerve endings;

排除标准

  • Persons unable to safely undergo an MRI (may include persons with an implanted device or metallic fragments which may interfere with MRI safety);
  • Persons with pre-existing conditions that would preclude satisfactory sural nerve harvest (may include amputation or major injury to lower limb, or disease affecting the sural nerve);
  • Persons with severe peripheral nerve injury gap length > 10 cm in length;
  • Persons with history of radiation or local cancer in area of nerve injury, including primary tumors of the nerve;
  • Pregnant women or a positive pregnancy test in those women with reproductive potential prior to transplantation;
  • Presence of disease that might interfere with participant

研究者

发起方
W. Dalton Dietrich
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

W. Dalton Dietrich

Professor

University of Miami

研究点 (1)

Loading locations...

相似试验